GlassScriptPhysician profile
Michael Steven Oleksyk
NPI 1437145000
$365,146.89
in general payments reported to CMS, 2019-2025
8 companies · $22.40 in 2025
The $22.40 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98K · 2020: $35K · 2021: $72K · 2022: $83K · 2023: $34K · 2024: $43K · 2025: $22.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $49K · Consulting Fee: $15K · Travel and Lodging: $10K · Food and Beverage: $2,543 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $48,865.00 |
| Consulting Fee | $15,480.00 |
| Travel and Lodging | $10,374.15 |
| Food and Beverage | $2,542.55 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $360,626.69 | 2019-2024 | Xarelto |
| Portola Pharmaceuticals, LLC | $2,465.75 | 2019 | |
| Amgen INC. | $1,437.66 | 2019 | |
| Cepheid | $413.00 | 2020 | |
| Csl Behring | $81.44 | 2024-2025 | Kcentra |
| Inari Medical, INC. | $43.68 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Bioxcel Therapeutics, INC. | $40.89 | 2023 | Igalmi |
| Janssen Scientific Affairs, LLC | $37.78 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Oleksyk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.